Increased visual cortical excitability in ecstasy users: A transcranial magnetic stimulation study

Journal of Neurology Neurosurgery and Psychiatry

Volumn 74, Issue 8, 2003, Pages 1136-1138

  Oliveri, M ^a,b   Calvo, G ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE;

ADULT; ARTICLE; BRAIN FUNCTION; CLINICAL ARTICLE; DRUG DEPENDENCE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NERVE EXCITABILITY; NEUROTOXICITY; OCCIPITAL CORTEX; PRIORITY JOURNAL; SEROTONIN RELEASE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULUS RESPONSE; TRANSCRANIAL MAGNETIC STIMULATION; VISUAL CORTEX; VISUAL HALLUCINATION; VISUAL STIMULATION;

EID: 0043207306     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.74.8.1136     Document Type: Article

References (16)

1. Sprague JE, Everman SL, Nichols DE. An integrated hypothesis for the serotonergic axonal loss induced by 3,4-methylenedioxymethamphetamine. Neurotoxicology 1998;19:427-41.
2. Reneman L, Booij J, de Bruin K, et al. Effects of dose, sex, and long-term abstention from use on toxic effects of 3,4-methylenedioxymethamphetamine ("Ecstasy") users: preliminary results. Lancet 2001;358:1864-9.
3. McCann UD, Szabo Z, Scheffel U, et al. Positron emission tomographic evidence of toxic effects of MDMA ("Ectasy") on brain serotonin neurons in human beings. Lancet 1998;352:1433-7.
4. Chang L, Grob CS, Ernst T, et al. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow: a co-registered SPECT and MRI study. Psychiatry Res 2000;98:15-28.
5. Reneman L, Booij J, Majoie CB, et al. Investigating the potential neurotoxicity of Ecstasy (MDMA): an imaging approach. Hum Psychopharmacol 2001;16:579-88.
6. Scheffel U, Szabo Z, Mathews WB, et al. In vivo detection of short- and long-term MDMA neurotoxicity - a positron emission tomography study in the living baboon brain. Synapse 1998;29:183-92.
7. Marg E, Rudiak D. Phosphenes induced by magnetic stimulation over the occipital brain: description and probable site of stimulation. Optom Vis Sci 1994;71:301-11.
8. Boroojerdi B, Bushara KO, Corwell B, et al. Enhanced excitability of the human visual cortex induced by short-term light deprivation. Cereb Cortex 2000;10:529-34.
9. Reneman L, Boij J, Schmand B, et al. Memory disturbances in "Ecstasy" users are correlated with an altered serotonin neurotransmission. Psychopharmacology 2000;148:322-4.
10. Dafters RI, Duffy F, O'Donnell PJ, et al. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") in humans correlates with EEG power and coherence. Psychopharmacology 1999;145:82-90.
11. Morgan MJ. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 2000;152:230-48.
12. Mulleners WM, Chronicle EP, Vredeveld JW, et al. Visual cortex excitability in migraine before and after valproate prophylaxis: a pilot study using TMS. Eur J Neurol 2002;9:35-40.
13. Kosslyn SM, Pascual-Leone A, Felician O, et al. The role of area 17 in visual imagery: convergent evidence from PET and rTMS. Science 1999;284:167-70.
14. Klein I, Paradis AL, Poline JP, et al. Transient activity in the human calcarine cortex during visual-mental imagery: an event-related fMRI study. J Cogn Neurosci 2000;12:15-23.
15. ffytche DH, Howard RJ, Brammer MJ, et al. The anatomy of conscious vision: an fMRI study of visual hallucinations. Nat Neurosci 1998;1:738-42.
16. Aleman A. Hallucinations and the cerebral hemispheres. J Psychiatry Neurosci 2001;26:64-5.